Microtubule alterations have been closely associated with AD, mainly due to tau dysfunction, which drives aberrant microtubule dynamics in vivo and in vitro (Qu et al., 2017; Peña-Ortega et al., 2022). Here, MAPT is linked to Alzheimer disease.